19613 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 393 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
FAM83CFamily with sequence similarity 83 member CPlasma proteins
Predicted intracellular proteins
Group enriched
FAM83DFamily with sequence similarity 83 member DPredicted intracellular proteins
Renal cancer: 1.81e-14
Liver cancer: 5.44e-6
Pancreatic cancer: 4.73e-5
Endometrial cancer: 1.49e-4
Lung cancer: 9.69e-4
Tissue enhanced
FAM83EFamily with sequence similarity 83 member EPredicted intracellular proteins
Tissue enhanced
FAM83FFamily with sequence similarity 83 member FPredicted intracellular proteins
Nucleus
Mitochondria
Colorectal cancer: 1.73e-4
Pancreatic cancer: 9.40e-4
Tissue enhanced
FAM83GFamily with sequence similarity 83 member GPredicted intracellular proteins
CytosolStomach cancer: 7.58e-6
Liver cancer: 8.29e-4
Tissue enhanced
FAM83HFamily with sequence similarity 83 member HDisease related genes
Predicted intracellular proteins
CytosolLung cancer: 3.77e-4
Stomach cancer: 4.42e-4
Tissue enhanced
FAM83H-AS1FAM83H antisense RNA 1 (head to head)Predicted intracellular proteins
Tissue enhanced
FAM84AFamily with sequence similarity 84 member APredicted intracellular proteins
NucleusMixed
FAM84BFamily with sequence similarity 84 member BPredicted intracellular proteins
NucleoplasmRenal cancer: 1.96e-8
Urothelial cancer: 1.75e-5
Endometrial cancer: 9.71e-4
Mixed
FAM86B1Family with sequence similarity 86 member B1Predicted intracellular proteins
VesiclesTissue enhanced
FAM86B2Family with sequence similarity 86 member B2Predicted intracellular proteins
VesiclesTissue enhanced
FAM86C1Family with sequence similarity 86 member C1Predicted intracellular proteins
Liver cancer: 5.79e-5
Mixed
FAM89AFamily with sequence similarity 89 member APredicted intracellular proteins
Nucleoplasm
Golgi apparatus
Vesicles
Renal cancer: 1.75e-5
Expressed in all
FAM89BFamily with sequence similarity 89 member BPredicted intracellular proteins
Renal cancer: 9.48e-5
Liver cancer: 2.98e-4
Ovarian cancer: 6.00e-4
Expressed in all
FAM8A1Family with sequence similarity 8 member A1Predicted membrane proteins
Transporters
Golgi apparatusExpressed in all
FAM90A1Family with sequence similarity 90 member A1Predicted intracellular proteins
Endometrial cancer: 3.92e-4
Tissue enhanced
FAM90A26Family with sequence similarity 90 member A26Predicted intracellular proteins
Not detected
FAM91A1Family with sequence similarity 91 member A1Predicted intracellular proteins
Nucleoplasm
Microtubules
Expressed in all
FAM92AFamily with sequence similarity 92 member APredicted intracellular proteins
MitochondriaTissue enriched
FAM92BFamily with sequence similarity 92 member BPredicted intracellular proteins
Tissue enriched
FAM96AFamily with sequence similarity 96 member APredicted secreted proteins
Nucleoplasm
Cytosol
Expressed in all
FAM96BFamily with sequence similarity 96 member BPredicted intracellular proteins
Nucleoplasm
Cytosol
Expressed in all
FAM98AFamily with sequence similarity 98 member APredicted intracellular proteins
VesiclesLiver cancer: 4.86e-7
Thyroid cancer: 8.18e-5
Expressed in all
FAM98BFamily with sequence similarity 98 member BPlasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Vesicles
Expressed in all
FAM98CFamily with sequence similarity 98 member CPredicted intracellular proteins
Nucleus
Nucleoli
Cytosol
Ovarian cancer: 8.51e-5
Urothelial cancer: 5.53e-4
Mixed
FAM9AFamily with sequence similarity 9 member APredicted intracellular proteins
Tissue enriched
FAM9BFamily with sequence similarity 9 member BPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
NucleoplasmTissue enriched
FAM9CFamily with sequence similarity 9 member CPredicted intracellular proteins
Predicted membrane proteins
Tissue enriched
FAN1FANCD2 and FANCI associated nuclease 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleoplasm
Cytokinetic bridge
Cytosol
Renal cancer: 1.42e-6
Expressed in all
FANCAFanconi anemia complementation group ACancer-related genes
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
NucleusMixed
FANCBFanconi anemia complementation group BDisease related genes
Predicted intracellular proteins
Mixed
FANCCFanconi anemia complementation group CCancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
NucleoplasmRenal cancer: 6.03e-6
Mixed
FANCD2Fanconi anemia complementation group D2Cancer-related genes
Disease related genes
Predicted intracellular proteins
Nucleus
Nucleoli
Nuclear bodies
Cytosol
Ovarian cancer: 5.00e-5
Mixed
FANCD2OSFANCD2 opposite strandPredicted intracellular proteins
Tissue enriched
FANCEFanconi anemia complementation group ECancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
NucleoplasmLiver cancer: 2.08e-9
Endometrial cancer: 6.25e-4
Mixed
FANCFFanconi anemia complementation group FCancer-related genes
Disease related genes
Predicted intracellular proteins
Liver cancer: 2.27e-4
Mixed
FANCGFanconi anemia complementation group GCancer-related genes
Disease related genes
Predicted intracellular proteins
Nucleoli
Plasma membrane
Cytosol
Renal cancer: 2.38e-7
Liver cancer: 2.02e-4
Mixed
FANCIFanconi anemia complementation group IDisease related genes
Predicted intracellular proteins
NucleoplasmRenal cancer: 2.71e-13
Liver cancer: 1.11e-4
Pancreatic cancer: 3.59e-4
Tissue enhanced
FANCLFanconi anemia complementation group LDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nuclear bodies
Vesicles
Renal cancer: 1.12e-7
Liver cancer: 2.81e-7
Urothelial cancer: 7.80e-5
Expressed in all
FANCMFanconi anemia complementation group MEnzymes
Predicted intracellular proteins
NucleoplasmTissue enhanced
FANK1Fibronectin type III and ankyrin repeat domains 1Predicted intracellular proteins
NucleoplasmEndometrial cancer: 3.83e-4
Group enriched
FAPFibroblast activation protein alphaCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Head and neck cancer: 4.82e-4
Tissue enhanced
FAR1Fatty acyl-CoA reductase 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
PeroxisomesColorectal cancer: 2.27e-4
Expressed in all
FAR2Fatty acyl-CoA reductase 2Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Nucleoli
Golgi apparatus
Renal cancer: 4.93e-4
Mixed
FARP1FERM, ARH/RhoGEF and pleckstrin domain protein 1Predicted intracellular proteins
CytosolRenal cancer: 1.39e-5
Mixed
FARP2FERM, ARH/RhoGEF and pleckstrin domain protein 2Predicted intracellular proteins
CytosolExpressed in all
FARS2Phenylalanyl-tRNA synthetase 2, mitochondrialDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Plasma membraneRenal cancer: 1.24e-6
Colorectal cancer: 5.14e-4
Expressed in all
FARSAPhenylalanyl-tRNA synthetase alpha subunitEnzymes
Predicted intracellular proteins
CytosolCervical cancer: 8.23e-4
Stomach cancer: 8.32e-4
Endometrial cancer: 9.22e-4
Expressed in all
FARSBPhenylalanyl-tRNA synthetase beta subunitEnzymes
Predicted intracellular proteins
Nucleus
Cytosol
Liver cancer: 6.45e-10
Renal cancer: 3.21e-5
Urothelial cancer: 1.25e-4
Expressed in all
FASFas cell surface death receptorCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Mixed
« prev | Page of 393 | next »